These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

437 related items for PubMed ID: 27444982

  • 1. Supraventricular and Ventricular Arrhythmias Are Related to the Type of Myotonic Dystrophy but Not to Disease Duration or Neurological Status.
    Bienias P, Łusakowska A, Ciurzyński M, Rymarczyk Z, Irzyk K, Kurnicka K, Kamińska A, Pruszczyk P.
    Pacing Clin Electrophysiol; 2016 Sep; 39(9):959-68. PubMed ID: 27444982
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Increased temporal dispersion of myocardial repolarization in myotonic dystrophy type 1: beyond the cardiac conduction system.
    Magrì D, Piccirillo G, Bucci E, Pignatelli G, Cauti FM, Morino S, Latino P, Santini D, Marrara F, Volpe M, Antonini G, Testa M.
    Int J Cardiol; 2012 May 03; 156(3):259-64. PubMed ID: 21112106
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Twenty-four-hour ambulatory ECG monitoring relevancy in myotonic dystrophy type 1 follow-up: Prognostic value and heart rate variability evolution.
    Gamet A, Degand B, Le Gal F, Bidegain N, Delaubier A, Gilbert-Dussardier B, Christiaens L, Garcia R.
    Ann Noninvasive Electrocardiol; 2019 Jan 03; 24(1):e12587. PubMed ID: 30101452
    [Abstract] [Full Text] [Related]

  • 7. Cardiac autonomic function in type 1 and type 2 myotonic dystrophy.
    Bienias P, Łusakowska A, Ciurzyński M, Rymarczyk Z, Irzyk K, Konwerski M, Ciąpała K, Kowalski P, Kamińska A, Pruszczyk P.
    Clin Auton Res; 2017 Jun 03; 27(3):193-202. PubMed ID: 28321519
    [Abstract] [Full Text] [Related]

  • 8. [Cardiac abnormalities in patients with myotonic dystrophy--preliminary results].
    Derejko P, Banach M, Hasiec A, Antczak J, Rola R, Sierpiński R, Miśko J, Wójcik A, Kępski R, Szumowski L.
    Przegl Lek; 2015 Jun 03; 72(4):178-83. PubMed ID: 26455015
    [Abstract] [Full Text] [Related]

  • 9. Spectrum and prognostic significance of arrhythmias on ambulatory Holter electrocardiogram in hypertrophic cardiomyopathy.
    Adabag AS, Casey SA, Kuskowski MA, Zenovich AG, Maron BJ.
    J Am Coll Cardiol; 2005 Mar 01; 45(5):697-704. PubMed ID: 15734613
    [Abstract] [Full Text] [Related]

  • 10. Optical Mapping Approaches on Muscleblind-Like Compound Knockout Mice for Understanding Mechanistic Insights Into Ventricular Arrhythmias in Myotonic Dystrophy.
    Chou CC, Chang PC, Wei YC, Lee KY.
    J Am Heart Assoc; 2017 Apr 17; 6(4):. PubMed ID: 28416514
    [Abstract] [Full Text] [Related]

  • 11. The frequency and severity of cardiac involvement in myotonic dystrophy type 2 (DM2): long-term outcomes.
    Sansone VA, Brigonzi E, Schoser B, Villani S, Gaeta M, De Ambroggi G, Bandera F, De Ambroggi L, Meola G.
    Int J Cardiol; 2013 Sep 30; 168(2):1147-53. PubMed ID: 23266299
    [Abstract] [Full Text] [Related]

  • 12. Medication adherence in patients with myotonic dystrophy and facioscapulohumeral muscular dystrophy.
    Fitzgerald BP, Conn KM, Smith J, Walker A, Parkhill AL, Hilbert JE, Luebbe EA, Moxley RT.
    J Neurol; 2016 Dec 30; 263(12):2528-2537. PubMed ID: 27734165
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Peripheral nerve involvement in myotonic dystrophy type 2 - similar or different than in myotonic dystrophy type 1?
    Nojszewska M, Łusakowska A, Szmidt-Salkowska E, Gaweł M, Lipowska M, Sułek A, Krysa W, Rajkiewicz M, Seroka A, Kaczmarek K, Kamińska AM.
    Neurol Neurochir Pol; 2015 Dec 30; 49(3):164-70. PubMed ID: 26048604
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Association Between Mutation Size and Cardiac Involvement in Myotonic Dystrophy Type 1: An Analysis of the DM1-Heart Registry.
    Chong-Nguyen C, Wahbi K, Algalarrondo V, Bécane HM, Radvanyi-Hoffman H, Arnaud P, Furling D, Lazarus A, Bassez G, Béhin A, Fayssoil A, Laforêt P, Stojkovic T, Eymard B, Duboc D.
    Circ Cardiovasc Genet; 2017 Jun 30; 10(3):. PubMed ID: 28611030
    [Abstract] [Full Text] [Related]

  • 19. Incidence and predictors of sudden death, major conduction defects and sustained ventricular tachyarrhythmias in 1388 patients with myotonic dystrophy type 1.
    Wahbi K, Babuty D, Probst V, Wissocque L, Labombarda F, Porcher R, Bécane HM, Lazarus A, Béhin A, Laforêt P, Stojkovic T, Clementy N, Dussauge AP, Gourraud JB, Pereon Y, Lacour A, Chapon F, Milliez P, Klug D, Eymard B, Duboc D.
    Eur Heart J; 2017 Mar 07; 38(10):751-758. PubMed ID: 27941019
    [Abstract] [Full Text] [Related]

  • 20. Arrhythmic CArdiac DEath in MYotonic dystrophy type 1 patients (ACADEMY 1) study: the predictive role of programmed ventricular stimulation.
    Russo V, Papa AA, Rago A, Ciardiello C, Martino AM, Stazi A, Golino P, Calò L, Nigro G.
    Europace; 2022 Jul 21; 24(7):1148-1155. PubMed ID: 35861549
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.